Epilepsy Therapies & Diagnostics Development XVIII

REGISTRATION for the 2025 meeting is NOW OPEN.  Register HERE.

The conference focuses on issues related to Epilepsy Therapies & Diagnostic Developments (ETDD) from preclinical discoveries through clinical evaluations. The event is sponsored by The Epilepsy Study Consortium in collaboration with the University of Pennsylvania and the Epilepsy Foundation.

May 28 – 30, 2025

Lansdowne Resort
44050 Woodridge Parkway, Leesburg, Virginia 20176

Meeting Purpose

For more than three decades a group of individuals have been meeting on a biennial basis to discuss ways in which the process of bringing innovative therapies and devices to patients can be expedited. Participants include individuals from academia, from interested government agencies, as well as representatives from the pharmaceutical and device industries. The purpose of these meetings has been the exchange of ideas, discussion of roadblocks to therapeutic and diagnostic development, dialogue about regulatory strategies, and sharing of successful approaches. In addition, each meeting presents a pipeline of drugs and devices currently in development, and includes the Epilepsy Foundation's Shark Tank Competition, where novel innovations to improve the lives of people with epilepsy are presented.

If you have any questions about the conference, please contact The Epilepsy Study Consortium: Bree DiVentura or Tracy DeVito.

2025 Shark Tank Competition - Letters of Intent are due January 31, 2025  - CLOSED no longer accepting applications for 2025

One exciting feature of the conference is the Epilepsy Foundation Shark Tank Competition, which will be held on Thursday, May 29. This annual competition invites researchers, scientists, entrepreneurs, and more to submit their innovative new ideas in epilepsy treatment, care or community outreach benefiting people living with epilepsy. Finalists will be invited to present their product, concepts or candidates at the ETDD Conference.

The winner(s) will receive international recognition and compete for combined awards and investment of up to $250,000 to support the development or commercialization of an important new product, technology, or concept to help people with epilepsy.

2025 Travel Grants – application due date March 21, 2025 - EXTENDED due date April 11, 2025

The Epilepsy Foundation, the Epilepsy Study Consortium, and the Pediatric Epilepsy Research Foundation® have pooled their funds to provide travel grants to the conference for: Epilepsy Fellow/Junior Faculty and Pediatric Epilepsy Fellows. Please see guidelines to apply.  

2025 Lifetime Accelerator Award - nominations due March 21, 2025 - CLOSED no longer accepting applications for 2025

The Lifetime Accelerator Award was established in 2012 to honor physicians, scientists, industry leaders, and others who have demonstrated a lifelong commitment to bringing new therapies to people living with epilepsy. Recipients are chosen by an independent committee of global thought leaders and clinical investigators in epilepsy and seizure therapy discovery and development. Learn more.